New Dell Healthcare CMO Comments on Company's Genomics Focus

Genetics Investing

Dell Healthcare and Life Sciences (NASDAQ:DELL) announced a new CMO on Monday. Dr. Nick van Terheyden will take over the position, a month after stepping down as CMIO at Nuance Communications.

Dell Healthcare and Life Sciences (NASDAQ:DELL) announced a new CMO on Monday. Dr. Nick van Terheyden will take over the position, a month after stepping down as CMIO at Nuance Communications.
According to an article published on MedCityNews:

Plano, Texas-based Dell Healthcare & Life Sciences has groups focused on mobile health, cloud computing, cybersecurity and genomics, among other areas. Dell’s healthcare cloud currently stores about 9 billion medical images, van Terheyden said, and most are tied to analytics systems.
In the area of genomics, Dell is partnering with the Translational Genomics Research Institute (TGen) on what the company says is the first FDA-approved personalized medicine trial for pediatric cancer.

Van Terheyden, a supporter of genomics research, states:

I’m very much in the Eric Topol camp of where things are going.

Click here to read the full article on MedCityNews.
 

The Conversation (0)
×